Information Journal Paper
APA:
Copy. (2018). Nanoencapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, 46(-), 917-925. SID. https://sid.ir/paper/721574/en
Vancouver:
Copy. Nanoencapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY[Internet]. 2018;46(-):917-925. Available from: https://sid.ir/paper/721574/en
IEEE:
Copy, “Nanoencapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells,” ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, vol. 46, no. -, pp. 917–925, 2018, [Online]. Available: https://sid.ir/paper/721574/en